annual CFI:
-$17.77M-$185.77M(-110.58%)Summary
- As of today (September 16, 2025), RARE annual cash flow from investing activities is -$17.77 million, with the most recent change of -$185.77 million (-110.58%) on December 31, 2024.
- During the last 3 years, RARE annual CFI has risen by +$177.60 million (+90.91%).
- RARE annual CFI is now -110.58% below its all-time high of $168.00 million, reached on December 31, 2023.
Performance
RARE Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$71.17M-$48.72M(-40.63%)Summary
- As of today (September 16, 2025), RARE quarterly cash flow from investing activities is $71.17 million, with the most recent change of -$48.72 million (-40.63%) on June 30, 2025.
- Over the past year, RARE quarterly CFI has increased by +$10.61 million (+17.52%).
- RARE quarterly CFI is now -40.63% below its all-time high of $119.89 million, reached on March 31, 2025.
Performance
RARE quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$25.30M+$10.61M(+72.25%)Summary
- As of today (September 16, 2025), RARE TTM cash flow from investing activities is $25.30 million, with the most recent change of +$10.61 million (+72.25%) on June 30, 2025.
- Over the past year, RARE TTM CFI has dropped by -$86.98 million (-77.47%).
- RARE TTM CFI is now -84.94% below its all-time high of $168.00 million, reached on December 31, 2023.
Performance
RARE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RARE Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -110.6% | +17.5% | -77.5% |
| 3 y3 years | +90.9% | -10.1% | -63.9% |
| 5 y5 years | -36.3% | +182.6% | +172.9% |
RARE Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -110.6% | +93.9% | -40.6% | +126.5% | -84.9% | +108.7% |
| 5 y | 5-year | -110.6% | +93.9% | -40.6% | +126.5% | -84.9% | +108.7% |
| alltime | all time | -110.6% | +93.9% | -40.6% | +126.5% | -84.9% | +108.7% |
RARE Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $71.17M(-40.6%) | $25.30M(+72.2%) |
| Mar 2025 | - | $119.89M(+16.7%) | $14.69M(-236.4%) |
| Dec 2024 | -$17.77M(-110.6%) | $102.73M(-138.3%) | -$10.77M(-95.1%) |
| Sep 2024 | - | -$268.50M(-543.3%) | -$220.52M(-296.4%) |
| Jun 2024 | - | $60.56M(-35.9%) | $112.28M(-25.7%) |
| Mar 2024 | - | $94.44M(-188.2%) | $151.13M(-10.0%) |
| Dec 2023 | $168.00M(-157.6%) | -$107.02M(-266.4%) | $168.00M(+62.4%) |
| Sep 2023 | - | $64.30M(-35.3%) | $103.42M(-184.3%) |
| Jun 2023 | - | $99.42M(-10.7%) | -$122.74M(-14.2%) |
| Mar 2023 | - | $111.30M(-164.9%) | -$142.99M(-51.0%) |
| Dec 2022 | -$291.65M(+49.3%) | -$171.60M(+6.0%) | -$291.65M(+471.9%) |
| Sep 2022 | - | -$161.86M(-304.5%) | -$51.00M(-172.7%) |
| Jun 2022 | - | $79.17M(-311.9%) | $70.10M(-239.3%) |
| Mar 2022 | - | -$37.36M(-154.1%) | -$50.31M(-74.2%) |
| Dec 2021 | -$195.37M(+9.1%) | $69.06M(-269.4%) | -$195.37M(+17.3%) |
| Sep 2021 | - | -$40.76M(-1.2%) | -$166.53M(-24.8%) |
| Jun 2021 | - | -$41.25M(-77.4%) | -$221.53M(-16.9%) |
| Mar 2021 | - | -$182.42M(-286.3%) | -$266.42M(+48.7%) |
| Dec 2020 | -$179.12M(+1273.7%) | $97.90M(-202.2%) | -$179.12M(-14.6%) |
| Sep 2020 | - | -$95.76M(+11.2%) | -$209.76M(+504.8%) |
| Jun 2020 | - | -$86.14M(-9.4%) | -$34.68M(+397.5%) |
| Mar 2020 | - | -$95.13M(-241.4%) | -$6.97M(-46.5%) |
| Dec 2019 | -$13.04M(-60.9%) | $67.27M(-15.2%) | -$13.04M(+93.3%) |
| Sep 2019 | - | $79.31M(-235.8%) | -$6.74M(-90.3%) |
| Jun 2019 | - | -$58.43M(-42.3%) | -$69.85M(+10.0%) |
| Mar 2019 | - | -$101.19M(-237.6%) | -$63.50M(+90.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$33.33M(-160.1%) | $73.56M(+353.9%) | -$33.33M(-33.1%) |
| Sep 2018 | - | $16.20M(-131.1%) | -$49.79M(+37.5%) |
| Jun 2018 | - | -$52.07M(-26.7%) | -$36.20M(+594.6%) |
| Mar 2018 | - | -$71.03M(-224.4%) | -$5.21M(-109.2%) |
| Dec 2017 | $55.48M(-39.1%) | $57.10M(+91.7%) | $56.42M(-647.5%) |
| Sep 2017 | - | $29.79M(-241.3%) | -$10.30M(-175.3%) |
| Jun 2017 | - | -$21.08M(+124.2%) | $13.68M(-76.7%) |
| Mar 2017 | - | -$9.40M(-2.2%) | $58.74M(-34.7%) |
| Dec 2016 | $91.12M(-131.2%) | -$9.62M(-117.9%) | $89.92M(+36.3%) |
| Sep 2016 | - | $53.77M(+124.2%) | $65.97M(-150.2%) |
| Jun 2016 | - | $23.99M(+10.2%) | -$131.51M(-50.7%) |
| Mar 2016 | - | $21.77M(-164.9%) | -$266.51M(-8.8%) |
| Dec 2015 | -$292.35M(+136.8%) | -$33.56M(-76.6%) | -$292.35M(+6.0%) |
| Sep 2015 | - | -$143.72M(+29.5%) | -$275.81M(+89.4%) |
| Jun 2015 | - | -$111.01M(+2630.9%) | -$145.64M(+134.5%) |
| Mar 2015 | - | -$4.07M(-76.1%) | -$62.11M(-49.7%) |
| Dec 2014 | -$123.44M(+158.6%) | -$17.02M(+25.7%) | -$123.44M(+29.5%) |
| Sep 2014 | - | -$13.54M(-50.7%) | -$95.31M(+15.5%) |
| Jun 2014 | - | -$27.48M(-58.0%) | -$82.55M(-15.8%) |
| Mar 2014 | - | -$65.40M(-688.5%) | -$98.03M(+105.4%) |
| Dec 2013 | -$47.73M(+3907.9%) | $11.11M(-1513.9%) | -$47.73M(-19.1%) |
| Sep 2013 | - | -$786.00K(-98.2%) | -$58.97M(+1.1%) |
| Jun 2013 | - | -$42.96M(+184.5%) | -$58.31M(+279.9%) |
| Mar 2013 | - | -$15.10M(>+9900.0%) | -$15.35M(+6138.2%) |
| Dec 2012 | -$1.19M(+28.9%) | -$124.00K(+1.6%) | -$246.00K(+101.6%) |
| Sep 2012 | - | -$122.00K | -$122.00K |
| Dec 2011 | -$924.00K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual CFI year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly CFI year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM CFI year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual cash flow from investing activities?
The current annual CFI of RARE is -$17.77M
What is the all time high annual CFI for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual cash flow from investing activities is $168.00M
What is Ultragenyx Pharmaceutical Inc. annual CFI year-on-year change?
Over the past year, RARE annual cash flow from investing activities has changed by -$185.77M (-110.58%)
What is Ultragenyx Pharmaceutical Inc. quarterly cash flow from investing activities?
The current quarterly CFI of RARE is $71.17M
What is the all time high quarterly CFI for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly cash flow from investing activities is $119.89M
What is Ultragenyx Pharmaceutical Inc. quarterly CFI year-on-year change?
Over the past year, RARE quarterly cash flow from investing activities has changed by +$10.61M (+17.52%)
What is Ultragenyx Pharmaceutical Inc. TTM cash flow from investing activities?
The current TTM CFI of RARE is $25.30M
What is the all time high TTM CFI for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM cash flow from investing activities is $168.00M
What is Ultragenyx Pharmaceutical Inc. TTM CFI year-on-year change?
Over the past year, RARE TTM cash flow from investing activities has changed by -$86.98M (-77.47%)